Skip to main content
Premium Trial:

Request an Annual Quote

LifeSensors To Launch Ubiquitin Traps Next Month

Premium

LifeSensors this week announced it has exclusively licensed on a global basis high-affinity ubiquitin traps developed by Manuel Rodriguez and will launch them in October.

Rodriguez is the group leader in proteomics at CIC bioGUNE, a bioscience research center in Spain. The traps, called Tandem-repeated Ubiquitin Binding Entities, or TUBEs, are based on protein domains with an affinity for ubiquitin and were developed to purify ubiquitylated proteins, the company said in a statement. TUBEs display up to a 1,000-fold increase in affinity for poly-ubiquitin moieties over a single ubiquitin binding domain.

Ubiquitin pathway proteins play significant roles in a number of diseases such as neurodegenerative ailments and cancer. Ubiquitylated proteins are unstable, however, and the ubiquitylation state of many proteins is poorly characterized. TUBEs, LifeSensors said, fills this void in ubiquitin research, by allowing the identification of ubiquitin-modified proteins that cannot otherwise be detected.

Proteins can be purified from cells, tissues, and organs with TUBES, the company added.

LifeSensors, based in Malvern, Penn., discovers, develop, and manufactures SUMO-based proteins expression technologies and ubiquitin research tools.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.